Literature DB >> 34281598

Differing susceptibility of C57BL/6J and DBA/2J mice-parents of the murine BXD family, to severe acute respiratory syndrome coronavirus infection.

Kui Li1, Yang Shen2, Mark A Miller2, Jennifer Stabenow3, Robert W Williams4, Lu Lu4.   

Abstract

The ongoing coronavirus disease-2019 (COVID-19) pandemic, caused by a novel coronavirus termed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that is closely related to SARS-CoV, poses a grave threat to global health and has devastated societies worldwide. One puzzling aspect of COVID-19 is the impressive variation in disease manifestations among infected individuals, from a majority who are asymptomatic or exhibit mild symptoms to a smaller, largely age-dependent fraction who develop life-threatening conditions. Some of these differences are likely the consequence of host genetic factors. Systems genetics using diverse and replicable cohorts of isogenic mice represents a powerful way to dissect those host genetic differences that modulate microbial infections. Here we report that the two founders of the large BXD family of mice-C57BL/6J and DBA/2J, differ substantially in their susceptibility to a mouse-adapted SARS-CoV, MA15. Following intranasal viral challenge, DBA/2J develops a more severe disease than C57BL/6J as evidenced by more pronounced and sustained weight loss. Disease was accompanied by high levels of pulmonary viral replication in both strains early after infection but substantially delayed viral clearance in DBA/2J. Our data reveal that the parents of the BXD family are segregated by clear phenotypic differences during MA15 infection and support the feasibility of using this family to systemically dissect the complex virus-host interactions that modulate disease progression and outcome of infection with SARS-CoV, and provisionally also with SARS-CoV-2.
© 2021. The Author(s).

Entities:  

Keywords:  BXD family; C57BL/6J; Coronavirus disease-2019; DBA/2J; SARS-CoV-2; Severe acute respiratory syndrome coronavirus; Susceptibility; Systems genetics; Viral replication; Weight loss

Year:  2021        PMID: 34281598     DOI: 10.1186/s13578-021-00656-8

Source DB:  PubMed          Journal:  Cell Biosci        ISSN: 2045-3701            Impact factor:   7.133


  9 in total

1.  Age-specific mortality and immunity patterns of SARS-CoV-2.

Authors:  Simon Cauchemez; Henrik Salje; Megan O'Driscoll; Gabriel Ribeiro Dos Santos; Lin Wang; Derek A T Cummings; Andrew S Azman; Juliette Paireau; Arnaud Fontanet
Journal:  Nature       Date:  2020-11-02       Impact factor: 49.962

2.  A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice.

Authors:  Anjeanette Roberts; Damon Deming; Christopher D Paddock; Aaron Cheng; Boyd Yount; Leatrice Vogel; Brian D Herman; Tim Sheahan; Mark Heise; Gillian L Genrich; Sherif R Zaki; Ralph Baric; Kanta Subbarao
Journal:  PLoS Pathog       Date:  2007-01       Impact factor: 6.823

Review 3.  Giving the Genes a Shuffle: Using Natural Variation to Understand Host Genetic Contributions to Viral Infections.

Authors:  Sarah R Leist; Ralph S Baric
Journal:  Trends Genet       Date:  2018-08-18       Impact factor: 11.639

4.  Genetic Dissection of the Regulatory Mechanisms of Ace2 in the Infected Mouse Lung.

Authors:  Fuyi Xu; Jun Gao; Silke Bergmann; Amy C Sims; David G Ashbrook; Ralph S Baric; Yan Cui; Colleen B Jonsson; Kui Li; Robert W Williams; Klaus Schughart; Lu Lu
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

5.  Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus.

Authors:  Santhana G Devaraj; Nan Wang; Zhongbin Chen; Zihong Chen; Monica Tseng; Naina Barretto; Rongtuan Lin; Clarence J Peters; Chien-Te K Tseng; Susan C Baker; Kui Li
Journal:  J Biol Chem       Date:  2007-08-30       Impact factor: 5.157

6.  A platform for experimental precision medicine: The extended BXD mouse family.

Authors:  David G Ashbrook; Danny Arends; Pjotr Prins; Megan K Mulligan; Suheeta Roy; Evan G Williams; Cathleen M Lutz; Alicia Valenzuela; Casey J Bohl; Jesse F Ingels; Melinda S McCarty; Arthur G Centeno; Reinmar Hager; Johan Auwerx; Lu Lu; Robert W Williams
Journal:  Cell Syst       Date:  2021-01-19       Impact factor: 10.304

7.  MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.

Authors:  Timothy Sheahan; Thomas E Morrison; William Funkhouser; Satoshi Uematsu; Shizou Akira; Ralph S Baric; Mark T Heise
Journal:  PLoS Pathog       Date:  2008-12-12       Impact factor: 6.823

Review 8.  SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon.

Authors:  Allison L Totura; Ralph S Baric
Journal:  Curr Opin Virol       Date:  2012-05-07       Impact factor: 7.090

Review 9.  Characteristics of SARS-CoV-2 and COVID-19.

Authors:  Ben Hu; Hua Guo; Peng Zhou; Zheng-Li Shi
Journal:  Nat Rev Microbiol       Date:  2020-10-06       Impact factor: 78.297

  9 in total
  1 in total

1.  Kinetic of the Antibody Response Following AddaVax-Adjuvanted Immunization with Recombinant Influenza Antigens.

Authors:  Ted M Ross; Naveen Gokanapudi; Pan Ge; Hua Shi; Robert A Richardson; Spencer R Pierce; Pedro Sanchez; Subhan Ullah; Eliana De Luca; Giuseppe A Sautto
Journal:  Vaccines (Basel)       Date:  2022-08-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.